Press Releases

GlobeNewswire, Inc.

48% of the Company's total net sales come from products with optimal nutritional quality.

GlobeNewswire, Inc.

BERKELEY HEIGHTS, N.J., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or “the Company”), a fully integrated, commercial-stage biopharmaceutical company, today announced an oral presentation on...

GlobeNewswire, Inc.

October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this month Project aims to help cardiac patients avoid...

Washington State Department of Ecology

Tracking the health of Puget Sound doesn’t stop when we get to the bottom of the sea. The sediments below the water and the critters that live in it, known as benthic organisms, are critical components of the whole system.

GlobeNewswire, Inc.

MONTREAL and CHARLOTTE, N.C., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced...

GlobeNewswire, Inc.

Third quarter 2026 total revenues increased by 21% to US$117.6 million, compared to third quarter 2025, exceeding market expectations RUCONEST® revenue increased by 14% to US$93.8 million, compared to third quarter 2025, reflecting demand...

GlobeNewswire, Inc.

VANCOUVER, British Columbia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed...

GlobeNewswire, Inc.

October 8, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous (SC) (efgartigimod...

GlobeNewswire, Inc.

Clinically relevant reduction in urinary incontinence episodes consistently maintained overtime including in the initial set of patients reaching end of study at 52 weeks Treatment was well tolerated, with no serious drug related side effects or...

GlobeNewswire, Inc.

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176) First Phase 2 evidence that blocking CD122 can prevent gluten-induced intestinal damage in people living with celiac disease argenx plans to advance FB102 into...

GlobeNewswire, Inc.

Global specialty chemicals leader Nouryon today announced the company has received clearance to supply a key pharmaceutical ingredient for medicines made and sold in China, one of the world’s largest drug manufacturing markets.

GlobeNewswire, Inc.

CRANSTON, R.I., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global provider of healthcare packaging solutions, announced it has been named a Dupont™ Tyvek® Sustainable Healthcare Packaging Awards winner in the...

GlobeNewswire, Inc.

ENGLEWOOD CLIFFS, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Circle8 Group, Inc. (Nasdaq: CIRC) today announced that its Dutch operating company, Circle8 Netherlands, has signed a four-year contract covering the Dutch Ministry of Health, Welfare and...

GlobeNewswire, Inc.

MELBOURNE, Australia and OXFORD, United Kingdom, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces it will be...

GlobeNewswire, Inc.

NAARDEN, The Netherlands and MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...

DVIDS - Georgia

In Japan, Exercise Keen Sword 27 is underway between the U.S. military, Japanese Self-Defense Forces, and members from Australia, Canada, France, Germany, the Netherlands, New Zealand and the Philippines.

GlobeNewswire, Inc.

A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis First clinical proof of principle.

GlobeNewswire, Inc.

Webinar will include earnings updates and REC-4881 data as well as KOL and patient panels, presented live from CGA-IGC on Tuesday, November 3, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Third quarter 2026 results will be released prior to the...

GlobeNewswire, Inc.

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.

GlobeNewswire, Inc.

WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the final results of its tender...